The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 1, 2014, Pages 338-343

  Makimura, Hideo ^a   Murphy, Caitlin A ^a   Feldpausch, Meghan N ^a   Grinspoon, Steven K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CREATINE PHOSPHATE; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; PLACEBO; SOMATOMEDIN C; TESAMORELIN;

ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ETHNICITY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MITOCHONDRION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; SEX; TREATMENT DURATION; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE;

ADULT; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY; PHOSPHOCREATINE; PLACEBOS; YOUNG ADULT;

EID: 84892167797     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3436     Document Type: Article

References (18)

1. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73:1081-1088.
2. Pijl H, Langendonk JG, Burggraaf J, et al. Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab. 2001;86:5509-5515.
3. Bonert VS, Elashoff JD, Barnett P, Melmed S. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J Clin Endocrinol Metab. 2004;89:3397-3401.
4. Makimura H, Stanley T, Mun D, You SM, Grinspoon S. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab. 2008;93:4254-4260.
5. Utz AL, Yamamoto A, Hemphill L, Miller KK. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J Clin Endocrinol Metab. 2008;93:2507-2514.
6. Makimura H, Feldpausch MN, Stanley TL, Sun N, Grinspoon SK. Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size. Clin Endocrinol (Oxf). 2012; 76:220-227.
7. Makimura H, Stanley T, Mun D, et al. Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity. J Clin Endocrinol Metab. 2009;94:5131-5138.
8. Makimura H, Feldpausch MN, Rope AM, et al. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial. J Clin Endocrinol Metab. 2012;97:4769-4779.
9. Makimura H, Stanley TL, Sun N, Hrovat MI, Systrom DM, Grinspoon SK. The association of growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men. J Clin Endocrinol Metab. 2011;96:817-823.
10. Befroy DE, Shulman GI. Magnetic resonance spectroscopy studies of human metabolism. Diabetes. 2011;60:1361-1369.
11. Perry CG, Kane DA, Lanza IR, Neufer PD. Methods for assessing mitochondrial function in diabetes. Diabetes. 2013;62:1041-1053.
12. Fleischman A, Makimura H, Stanley TL, et al. Skeletal muscle phosphocreatine recovery after submaximal exercise in children and young and middle-aged adults. J Clin Endocrinol Metab. 2010;95: E69-E74.
13. Roussel M, Bendahan D, Mattei JP, Le Fur Y, Cozzone PJ. 31P magnetic resonance spectroscopy study of phosphocreatine recovery kinetics in skeletal muscle: the issue of intersubject variability. Biochim Biophys Acta. 2000;1457:18-26.
14. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and softtissue composition. Am J Clin Nutr. 1990;51:1106-1112.
15. Short KR, Moller N, Bigelow ML, Coenen-Schimke J, Nair KS. Enhancement of muscle mitochondrial function by growth hormone. J Clin Endocrinol Metab. 2008;93:597-604.
16. Bredella MA, Gerweck AV, Lin E, et al. Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity. J Clin Endocrinol Metab. 2013;98:3864-3872
17. Stanley TL, Chen CY, Branch KL, et al. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. J Clin Endocrinol Metab. 2011; 96:150-158.
18. Vescovo G, Ravara B, Gobbo V, Angelini A, Dalla Libera L. Skeletal muscle fibres synthesis in heart failure: role of PGC-1 , calcineurin and GH. Int J Cardiol. 2005;104:298-306.